The company's capital structure appears fragile, evidenced by a $311.2M accumulated deficit and a debt-to-equity ratio of 0.52 as of 2026Q1.
| Total Current Assets | 82.45M | 81.9M | 46.11M | 39.94M | 51.26M | 135.81M | 37.61M | 25.61M |
| Cash & Short-Term Investments | 41.01M | 35.5M | 20.25M | 16.56M | 11.23M | 95.05M | 17.01M | 11.74M |
| Cash Only | 41.01M | 35.5M | 20.25M | 16.56M | 11.23M | 95.05M | 17.01M | 11.74M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 19.86M | 22.9M | 12.14M | 13.97M | 15.96M | 10.47M | 10.53M | 7.76M |
| Days Sales Outstanding | 81.57 | 79.07 | 56.75 | 94.43 | 84.17 | 50.38 | 50.95 | 56.91 |
| Inventory | 18.19M | 15.3M | 10.52M | 6.49M | 18.52M | 17.98M | 7.91M | 4.86M |
| Days Inventory Outstanding | 102.91 | 107.03 | 99.13 | 75.42 | 147.27 | 160.91 | 73.06 | 65.97 |
| Other Current Assets | 3.39M | 8.2M | 386K | 1 | 0 | 0 | 0 | 743K |
| Total Non-Current Assets | 4.3M | 3.7M | 3.4M | 4.18M | 6.84M | 4.23M | 2.5M | 2.59M |
| Property, Plant & Equipment | 720K | 400K | 240K | 1.31M | 3.37M | 1.87M | 1.72M | 1.85M |
| Fixed Asset Turnover | 241.40x | 264.27x | 325.23x | 41.10x | 20.55x | 40.56x | 43.89x | 26.86x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 1.75M | 1.4M | 975K | 2.21M | 2.28M | 1.7M | 605K | 624K |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | -89.71K | 0 |
| Other Non-Current Assets | 1.84M | 1.9M | 2.19M | 655K | 1.2M | 666K | 181K | 113K |
| Total Assets | 86.76M | 85.6M | 49.52M | 44.12M | 58.1M | 140.05M | 40.12M | 28.2M |
| Asset Turnover | 1.38x | 1.23x | 1.58x | 1.22x | 1.19x | 0.54x | 1.88x | 1.77x |
| Asset Growth % | 213.51% | 72.88% | 12.22% | -24.06% | -58.51% | 249.09% | 42.26% | - |
| Total Current Liabilities | 48.14M | 44.2M | 36.43M | 45.09M | 66.6M | 69.09M | 47.27M | 24.93M |
| Accounts Payable | 11.78M | 12M | 11.28M | 13.68M | 30.43M | 27.77M | 16.38M | 8.11M |
| Days Payables Outstanding | 94.15 | 83.95 | 106.27 | 158.89 | 242.06 | 248.49 | 151.25 | 110.07 |
| Short-Term Debt | 16.82M | 10.57M | 7.37M | 15.19M | 15.04M | 8.53M | 18.66M | 8.75M |
| Deferred Revenue (Current) | 6.83M | 2.3M | 0 | 0 | 0 | 1.06M | 1.64M | 0 |
| Other Current Liabilities | 12.89M | -94K | 2.31M | 4.08M | 8.62M | 0 | 0 | 3.38M |
| Current Ratio | 1.71x | 1.85x | 1.27x | 0.89x | 0.77x | 1.97x | 0.80x | 1.03x |
| Quick Ratio | 1.33x | 1.51x | 0.98x | 0.74x | 0.49x | 1.71x | 0.63x | 0.83x |
| Cash Conversion Cycle | 90.34 | 102.16 | 49.61 | 10.96 | -10.62 | -37.19 | -27.24 | 12.81 |
| Total Non-Current Liabilities | 2.77M | 5.93M | 34.23M | 28.71M | 2.14M | 15.77M | 13.67M | 13.94M |
| Long-Term Debt | 1.95M | 2.46M | 4.33M | 0 | 0 | 7.99M | 10.18M | 13.51M |
| Capital Lease Obligations | 0 | 0 | 87K | 22K | 1.16M | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 818K | 3.47M | 29.82M | 28.69M | 975K | 7.77M | 3.49M | 437K |
| Total Liabilities | 50.91M | 50.2M | 70.66M | 73.8M | 68.74M | 84.86M | 60.94M | 38.87M |
| Total Debt | 18.77M | 13.03M | 11.87M | 16.39M | 18.3M | 16.53M | 28.84M | 22.26M |
| Net Debt | -22.24M | -22.47M | -8.38M | -172K | 7.07M | -78.53M | 11.83M | 10.52M |
| Debt / Equity | 0.52x | 0.37x | - | - | - | 0.30x | - | - |
| Debt / EBITDA | -1.80x | - | - | - | - | - | - | - |
| Net Debt / EBITDA | 2.14x | - | - | - | - | - | - | - |
| Interest Coverage | -6.93x | -10.60x | -6.66x | -9.31x | -70.84x | -1.58x | -6.60x | - |
| Total Equity | 35.85M | 35.4M | -21.15M | -29.68M | -10.63M | 55.19M | -20.82M | -10.67M |
| Equity Growth % | 406.48% | 267.39% | 28.74% | -179.04% | -119.27% | 365.07% | -95.08% | - |
| Book Value per Share | 9.87 | 0.06 | -1.40 | -3.59 | -1.34 | 7.01 | -10.14 | -13.97 |
| Total Shareholders' Equity | 35.85M | 35.4M | -21.15M | -29.68M | -10.63M | 55.19M | -20.82M | -10.67M |
| Common Stock | 3K | 3K | 2K | 1K | 1K | 11K | 2K | 1K |
| Retained Earnings | -311.21M | -307.87M | -268.19M | -255.66M | -222.76M | -143.42M | -71.72M | -61.2M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Liquidity and solvency pressure
As reported in recent financial filings, Owlet's equity position has improved from a deficit of $48.9M in 2025Q2 to a positive $35.8M by 2026Q1, yet this recovery appears heavily reliant on external capital injections rather than organic accumulation of retained earnings.
The shift from negative to positive equity suggests a stabilization of the capital structure, but the persistent negative retained earnings of $311.2M indicate that the core business model has yet to achieve self-sustaining profitability. Investors should monitor whether this equity improvement is a durable trend or merely a temporary reprieve from capital market activities.
Based on the 2026Q1 balance sheet, the company maintains a current ratio of 1.71, which, while improved from the 1.01 levels seen in early 2024, still leaves a narrow buffer against the ongoing cash burn associated with medical-grade hardware development.
The current cash position of $41.0M provides a limited runway, particularly given the historical volatility in working capital requirements. Any unexpected disruption in retail sell-through or delays in regulatory-driven insurance reimbursement could rapidly deplete these reserves, necessitating further dilutive financing.
According to the latest quarterly data, Owlet's debt-to-equity ratio stands at 0.52, reflecting a strategic, albeit necessary, reliance on debt financing to bridge the gap between high R&D expenditures and the eventual commercialization of FDA-cleared medical devices.
While the debt load of $18.8M is not inherently excessive for a growth-stage med-tech firm, the lack of consistent positive operating cash flow makes this leverage a potential burden. The company's ability to service this debt appears contingent on its success in scaling high-margin software services to complement its hardware sales.
Financial statements reveal a staggering accumulated deficit of $311.2M as of 2026Q1, which serves as a stark reminder that historical capital allocation has struggled to generate returns exceeding the cost of the company's aggressive growth and regulatory compliance strategy.
This massive deficit suggests that the company's past investments in market share and product development have not yet translated into a profitable enterprise. Analysts should be wary of focusing solely on recent equity improvements, as the underlying historical losses remain a significant drag on the company's long-term financial health.
Quick answers to the most common questions about buying OWLT stock.
As of 2025, Owlet, Inc. (OWLT) had total assets of $85.6M including $81.9M in current assets.
Owlet, Inc. (OWLT) carries total debt of $13.0M, offset by $35.5M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Owlet, Inc. (OWLT) has total shareholders' equity (book value) of $35.4M ($0.06 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Owlet, Inc. (OWLT) reported a current ratio of 1.85x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.